The global genistein market is expected to reach a valuation of USD 23.5 Million by the year 2022, accelerating with a CAGR of 10.9 % by 2022 to 2032. The market for genistein is anticipated to be valued at USD 66.0 Million by the end of 2032.
Genistein is referred to as a natural isoflavone that is mainly found in soybeans, as well as soybean-enriched products. Numerous research studies have found that genistein has a wide range of beneficial properties such as anticancer activity, antioxidant, anthelmintic, and antiangiogenic.
As genistein mimics estrogen, it has the potential to help in cognitive functions, menopausal symptoms, and premenstrual syndrome. It is also capable of lessening the chances of hypertension, improving heart elasticity, and enlarging the heart.
It can reduce the risk of prostate cancer by lowering the levels of specific markers that often pose threats. It can also be beneficial for protecting an individual from hormonal-related cancers, as well as breast cancer by destroying the cancer cells.
In August 2022, for instance, Paula’s Choice, a research-based skincare company, announced the launch of CLINICAL Phytoestrogen Elasticity Renewal Body Treatment and CLINICAL Phytoestrogen Elasticity Renewal Serum to protect women against menopausal skin. The company uses three phytoestrogens to develop these latest products, namely, equol, genistein, and daidzein.
Similarly, OneSkin, a promoter of long-term skin care and health, introduced OS-01 Topical Supplement BODY in March 2022. It is a skin longevity supplement that can enhance skin texture, skin span, sun damage, barrier function, epidermal elasticity, and thickness. The company has combined OS-01 peptide with other unique ingredients like ceramides, phytochemical sulforaphane, sporocarp mushroom extract, and genistein.
Similar product launches by key companies are expected to augur well for the global market in the next ten years. Genistein can also act as a tyrosine kinase inhibitor. It can also act as a direct antioxidant to several isoflavones, thereby improving the damaging effects of free radicals, especially in tissues.
| Attributes | Key Insights |
|---|---|
| Global Genistein Market Estimated Size (2022E) | USD 23.5 Million |
| Projected Market Valuation (2032F) | USD 66.0 Million |
| Value-based CAGR (2022 to 2032) | 10.9% |
| Collective Value Share: Top 3 Countries | 50.9% |
Explore FMI!
Book a free demo
As per FMI, sales of nutraceuticals surged at a CAGR of 8.8% during the historical period between 2017 and 2021. Demand for genistein is anticipated to grow at a rapid pace in the next ten years fueled by its ability to lower postmenopausal symptoms such as vaginal dryness and hot flashes.
As per the Local Government Association, the average age for reaching menopause is 51 in the UK However, nearly 1 in 100 women showcase symptoms of menopause before 40 years of age. Symptoms include skin irritation, sleep disturbance, fatigue, chills, anxiety, muscular aches, and many more. Thus, dietary supplement manufacturers are expected to include innovative ingredients like genistein in their products to attract a large consumer base experiencing menopause.
Increasing Consumption of Dietary Supplements to Bolster Demand for Phytoestrogen Genistein
Owing to its multifaceted functionality, genistein is considered to be a potential ingredient for use in a wide variety of industrial applications. Ongoing expansion of the pharmaceutical, nutraceutical, and dietary supplement industries on the back of rising consumer awareness regarding preventive healthcare and surging per capita healthcare expenditure is projected to aid sales of the flavonoid.
Genistein is set to be utilized in the treatment of various chronic health issues such as osteoporosis, cancer, and cardiovascular disease. As it has health-aiding and therapeutic properties, its demand is anticipated to grow at a fast pace across the globe. In addition to that, it has properties like collagen synthesis, skin firming & smoothing, antioxidants, and anti-inflammatory. Thus, the genistein market is expected to grow with rising demand from personal care and cosmetics products manufacturers.
Need for Weight Management Solutions in the USA to Augment Sales of Genistein Isoflavones
As per FMI, North America is expected to generate a lion’s share of around 42.6% in the genistein market in the forecast period owing to increasing consumer focus towards maintaining a healthy lifestyle. High demand for weight management solutions is another vital factor that would encourage key companies to develop new application areas for genistein.
Rising Launch of Nutraceutical Products in China to Fuel the Demand for Genistein Tablets
In the assessment period, Asia Pacific is expected to develop at a fast pace. The region's rapid growth can be ascribed to increasing demand for healthy food items and changing lifestyles of consumers across China. Expansion of the nutraceutical industry in China backed by increasing consumer awareness regarding healthcare, weight loss, and calorie reduction is anticipated to drive the genistein market. A rapid shift of Chinese consumers towards preventive healthcare that includes consuming functional foods and dietary supplements on a daily basis to strengthen the immune system against various diseases would also spur sales.
Increasing Prevalence of Cancer and Obesity in the UK to Augment Sales of Genistein Capsules
In Europe, the UK is set to be a leading hub for genistein manufacturers on the back of the growing focus of consumers on following a healthy lifestyle. The increasing prevalence of obesity in the country is set to result in premature death with the occurrence of various types of cancer, hypertension, diabetes, stroke, and heart disease.
These factors are likely to compel consumers in the UK to move towards medications, dietary supplements, and nutraceuticals that would help in preventing the above-mentioned health issues. Owing to the aforementioned factors, demand for isoflavones like genistein is projected to grow at a fast pace in the UK
Need for Weight Management Solutions in the USA to Augment Sales of Genistein Isoflavones
As per FMI, North America is expected to generate a lion’s share of around 42.6% in the genistein market in the forecast period owing to increasing consumer focus towards maintaining a healthy lifestyle. High demand for weight management solutions is another vital factor that would encourage key companies to develop new application areas for genistein.
Rising Launch of Nutraceutical Products in China to Fuel the Demand for Genistein Tablets
In the assessment period, Asia Pacific is expected to develop at a fast pace. The region's rapid growth can be ascribed to increasing demand for healthy food items and changing lifestyles of consumers across China. Expansion of the nutraceutical industry in China backed by increasing consumer awareness regarding healthcare, weight loss, and calorie reduction is anticipated to drive the genistein market. A rapid shift of Chinese consumers towards preventive healthcare that includes consuming functional foods and dietary supplements on a daily basis to strengthen the immune system against various diseases would also spur sales.
Increasing Prevalence of Cancer and Obesity in the UK to Augment Sales of Genistein Capsules
In Europe, the UK is set to be a leading hub for genistein manufacturers on the back of the growing focus of consumers on following a healthy lifestyle. The increasing prevalence of obesity in the country is set to result in premature death with the occurrence of various types of cancer, hypertension, diabetes, stroke, and heart disease.
These factors are likely to compel consumers in the UK to move towards medications, dietary supplements, and nutraceuticals that would help in preventing the above-mentioned health issues. Owing to the aforementioned factors, demand for isoflavones like genistein is projected to grow at a fast pace in the UK
Demand for Genistein Powder to Grow Exponentially among Food and Beverage Manufacturers
Genistein-based food and beverages have exceptional characteristics and health benefits. Intake of genistein products has been attributed to lower incidence of breast and prostate cancer in human beings. Demand for high-beneficial meals infused with flavonoids is a result of increased consumer awareness. Furthermore, due to the high risk of cancer in humans, demand for food and beverages infused with genistein is anticipated to surge in the next ten years.
The pharmaceuticals segment, on the other hand, is projected to remain in the second position followed by food and beverages, finds FMI. Various biological effects of genistein have been reported in preclinical studies. The flavonoid contains antioxidant, anti-inflammatory, antibacterial, and antiviral properties. Some of the studies have found that genistein can lead to angiogenesis and estrogen production, as well as generate pharmacological activities on diabetes and lipid metabolism.
With a large number of manufacturers operating globally, the market for genistein is highly competitive. Key companies are investing huge sums in research and development, which is expected to boost overall growth over the forecast period. Furthermore, the rising focus of companies on expanding their product portfolios, as well as engaging in mergers and acquisitions are anticipated to provide significant growth opportunities to accelerate in the market throughout the evaluation period.
For instance,
| Attribute | Details |
|---|---|
| Estimated Market Size (2022) | USD 23.5 Million |
| Projected Market Valuation (2032) | USD 66.0 Million |
| Value-based CAGR (2022 to 2032) | 10.9% |
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | Value (USD Million) |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; and the Middle East & Africa |
| Key Countries Covered | USA, Brazil, Mexico, Germany, UK, China, India, Japan, Australia, and GCC Countries |
| Key Segments Covered | Form, Application and Region |
| Key Companies Profiled | Tocris Bioscience; Merck KGaA; Cayman Chemical; PhytogenX, Inc.; Pure Chemistry Scientific; MedChemexpress LLC; Abbas Chemicals; HBCChem, Inc.; Toronto Research Chemicals; Shanghai Tauto Biotech; Meyer Chemical Technology; ALB Technology Limited; Tokyo Chemical Industry; 3B Pharmachem (Wuhan) International; BeiJing Hwrk Chemicals; Du Pant Nutrition & Health |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The genistein industry is anticipated to reach nearly USD 23.5 Million by 2022.
The North America genistein industry is expected to register an 9.1% CAGR between 2022 and 2032.
The demand for genistein is expected to grow at a 10.9% CAGR between 2022 and 2032 in Europe.
Sales of genistein are predicted to be driven by rising health consciousness and changes in lifestyles of people around the world. Increasing trend for nutraceuticals is another crucial factor that would push sales.
The demand for genistein in China is expected to grow at 11.3% CAGR between 2022 and 2032.
Genistein Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
